| Michelle Babb Tarbox, MD | |
|
3601 4th St, Department Of Dermatology, Lubbock, TX 79430-9400 | |
| (806) 743-1842 | |
| (806) 743-2933 |
| Full Name | Michelle Babb Tarbox |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 19 Years |
| Location | 3601 4th St, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417277807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | 2010016527 (Missouri) | Secondary |
| 207N00000X | Dermatology | 2010016527 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center | Lubbock, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Tech University Health Sciences Center Lubbock | 4385549674 | 310 |
News Archive
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
A researcher at the University of Missouri-Columbia has found that girls who talk very extensively about their problems with friends are likely to become more anxious and depressed.
Treating chronic migraines with behavioral approaches - such as relaxation training, hypnosis and biofeedback - can make financial sense compared to prescription-drug treatment, especially after a year or more, a new study found.
BMG LABTECH, a leading manufacturer of microplate readers, recently supported four iGEM teams with a microplate reader to fuel their participation at the annual iGEM competition.
Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
› Verified 6 days ago
| Entity Name | Texas Tech University Health Sciences Center Lubbock |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063461358 PECOS PAC ID: 4385549674 Enrollment ID: O20110318000468 |
News Archive
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
A researcher at the University of Missouri-Columbia has found that girls who talk very extensively about their problems with friends are likely to become more anxious and depressed.
Treating chronic migraines with behavioral approaches - such as relaxation training, hypnosis and biofeedback - can make financial sense compared to prescription-drug treatment, especially after a year or more, a new study found.
BMG LABTECH, a leading manufacturer of microplate readers, recently supported four iGEM teams with a microplate reader to fuel their participation at the annual iGEM competition.
Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Babb Tarbox, MD 3601 4th St, Department Of Dermatology, Lubbock, TX 79430-9400 Ph: (806) 743-1842 | Michelle Babb Tarbox, MD 3601 4th St, Department Of Dermatology, Lubbock, TX 79430-9400 Ph: (806) 743-1842 |
News Archive
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
A researcher at the University of Missouri-Columbia has found that girls who talk very extensively about their problems with friends are likely to become more anxious and depressed.
Treating chronic migraines with behavioral approaches - such as relaxation training, hypnosis and biofeedback - can make financial sense compared to prescription-drug treatment, especially after a year or more, a new study found.
BMG LABTECH, a leading manufacturer of microplate readers, recently supported four iGEM teams with a microplate reader to fuel their participation at the annual iGEM competition.
Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
› Verified 6 days ago
Dr. Brent R. Paulger, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2202 Ithaca Ave, Lubbock, TX 79410 Phone: 806-797-1202 Fax: 806-797-4854 | |
Dr. Bryan Harris, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3715 21st St, Lubbock, TX 79410 Phone: 806-795-0610 Fax: 806-795-0602 | |
Ashley Sturgeon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2202 Ithaca Ave, Lubbock, TX 79410 Phone: 806-797-1202 Fax: 806-797-4854 | |
Dr. Michael David Long, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6012 82nd St Ste 15, Lubbock, TX 79424 Phone: 806-749-7933 Fax: 806-749-6117 | |
Dr. Amy Rocky Brackeen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4709 66th St, Lubbock, TX 79414 Phone: 806-701-5844 Fax: 806-701-5845 | |
Dr. Richard H Hope, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3601 22nd St, Lubbock, TX 79410 Phone: 806-796-7193 Fax: 809-796-0034 |